Micardis and Lopid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Micardis (telmisartan) and Lopid (gemfibrozil). Common drug interactions include pain among females and cyclitis among males.

The phase IV clinical study analyzes what interactions people have when they take Micardis and Lopid. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Micardis?

Micardis has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 27,605 Micardis users. Check the latest studies of Micardis.

What is Lopid?

Lopid has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 9,700 Lopid users. Check the latest studies of Lopid.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 04, 2026

31 people who take Micardis and Lopid together, and have interactions are studied.

Micardis and Lopid drug interactions.

What are the common drug interactions of Micardis and Lopid, by gender? *:

female:

  1. Pain
  2. Contusion (a type of hematoma of tissue in which capillaries)
  3. Dizziness
  4. Fall
  5. Fatigue (feeling of tiredness)
  6. Fungal infection
  7. Headache (pain in head)
  8. Heart rate increased
  9. Injection site erythema (redness at injection site)
  10. Overdose

male:

  1. Cyclitis (inflammation of the ciliary body (eye))
  2. Pancreatitis acute (sudden inflammation of pancreas)
  3. Flushing (the warm, red condition of human skin)
  4. Increased upper airway secretion
  5. Joint stiffness
  6. Monocyte count increased
  7. Myalgia (muscle pain)
  8. Oedema peripheral (superficial swelling)
  9. Pancreatitis (inflammation of pancreas)
  10. Pneumonia primary atypical (primary atypical pneumonia which were probably caused by mycoplasma pneumoniae)

What are the common drug interactions of Micardis and Lopid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Diabetes mellitus inadequate control
  3. Diabetic eye disease
  4. Hypoglycaemia (deficiency of glucose in the bloodstream)
  5. Nephrogenic diabetes insipidus (a disorder in which a defect in the small tubes (tubules) in the kidneys causes a person to pass a large amount of urine)
  6. Neuropathy peripheral (surface nerve damage)
  7. Cold sweat
  8. Vomiting

40-49:

n/a

50-59:

  1. Rash generalised (rash on most of body parts)
  2. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
  3. Flushing (the warm, red condition of human skin)
  4. Joint stiffness
  5. Pancreatitis (inflammation of pancreas)
  6. Renal disorder (kidney disease)
  7. Type 2 diabetes mellitus

60+:

  1. Dizziness
  2. Pain
  3. Overdose
  4. Pancreatitis acute (sudden inflammation of pancreas)
  5. Pelvic pain
  6. Cystitis (inflammation of the wall of the bladder)
  7. Depression
  8. Injection site haemorrhage (bleeding from injection site)
  9. Myalgia (muscle pain)
  10. Oedema peripheral (superficial swelling)

What are the existing conditions these people have? *

  1. Osteoporosis (bones weak and more likely to break): 6 people, 19.35%
  2. Fibromyalgia (a long-term condition which causes pain all over the body): 6 people, 19.35%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 16.13%
  4. Hypersensitivity: 3 people, 9.68%
  5. Dyslipidaemia (abnormal amount of lipids): 3 people, 9.68%
  6. Serum Ferritin Increased: 2 people, 6.45%
  7. Psoriasis (immune-mediated disease that affects the skin): 2 people, 6.45%
  8. Pain: 2 people, 6.45%
  9. Nausea (feeling of having an urge to vomit): 2 people, 6.45%
  10. Iron Overload: 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Micardis and Lopid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Micardis and Lopid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Micardis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lopid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Micardis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lopid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on telmisartan and gemfibrozil (the active ingredients of Micardis and Lopid, respectively), and Micardis and Lopid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: